Chemomab Therapeutics files updated corporate presentation on systemic sclerosis

Chemomab Therapeutics Ltd.

Presentation dated November 3, 2021, focuses on systemic sclerosis (SSc) program.
No specific clinical data or financial results disclosed in the excerpt provided.
Live webinar held same day to discuss the updated presentation.

item 7.01 item 9.01

Chemomab Therapeutics Ltd. filing history →

Source: SEC EDGAR

accession 0001178913-21-003370

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.